Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XUD
|
||||
Former ID |
DNC010676
|
||||
Drug Name |
4-(biphenyl-3-yl)-5-(piperidin-4-yl)isoxazol-3-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530818] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H20N2O2
|
||||
Canonical SMILES |
C1CNCCC1C2=C(C(=O)NO2)C3=CC=CC(=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C20H20N2O2/c23-20-18(19(24-22-20)15-9-11-21-12-10-15)17-8-4-7-16(13-17)14-5-2-1-3-6-14/h1-8,13,15,21H,9-12H2,(H,22,23)
|
||||
InChIKey |
KLKHVLINJXRNBG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [530818] | |
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [530818] | ||
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [530818] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.